Skip to main content

Genetic Innovation

Scientists uncover genetic innovation underlying evolution of ants


Scientists from the Global Ant Genomics Alliance on Monday published groundbreaking research in the international academic journal Cell, revealing the genetic foundations underlying major adaptive changes in ant evolution and their co-evolving social traits.

Despite their small size, ants display impressive organizational capabilities. They are able to build intricate nests without the use of language for communication, and they exhibit a remarkably efficient division of labor.

By analyzing the whole-genome data of 163 ant genomes collected worldwide, the research team reconstructed the evolutionary tree of the Formicidae family, encompassing 12 of its 16 extant subfamilies.


The team's research clarifies the complex phylogenetic relationships among ant species and traces the common ancestor of extant ants back to the late Jurassic period about 157 million years ago, shedding light on the origin of ant sociality in the age of dinosaurs.

The team discovered that gene families related to olfactory perception had significantly expanded in the genome of this common ancestor, suggesting it already possessed key molecular mechanisms for social communication.


The study also found that different ant species exhibit convergent mechanisms that regulate which ant becomes queen and which ants become workers, reflecting their adaptive evolution under natural selection.


The study involved collaboration between scientists from Zhejiang University, the Chinese Academy of Sciences, Nanchang University and BGI Research in China, as well as scientists from the University of Copenhagen in Denmark and the University of Münster in Germany.

genetic engineering, genome editing, CRISPR-Cas9, synthetic biology, gene therapy, precision medicine, DNA sequencing, genomics, personalized medicine, genetic diagnostics, epigenetics, genetic modification, RNA technology, functional genomics, biotechnology, genetic mapping, molecular biology, gene expression, pharmacogenomics, bioinformatics

#GeneticInnovation, #CRISPR, #GeneEditing, #SyntheticBiology, #GeneTherapy, #Genomics, #PrecisionMedicine, #Biotech, #DNATechnology, #PersonalizedMedicine, #GeneticResearch, #Epigenetics, #MolecularGenetics, #FunctionalGenomics, #BiotechRevolution, #RNAtech, #Pharmacogenomics, #Bioinformatics, #GeneticEngineering, #FutureOfMedicine

International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: genetics-conferences.healthcarek.com/award-nomination/?ecategory=Awards&rcategory=Awardee

Award registration: genetics-conferences.healthcarek.com/award-registration/

For Enquiries: contact@healthcarek.com

Get Connected Here
---------------------------------
---------------------------------
in.pinterest.com/Dorita0211
twitter.com/Dorita_02_11_
facebook.com/profile.php?id=61555903296992
instagram.com/p/C4ukfcOsK36
genetics-awards.blogspot.com/
youtube.com/@GeneticsHealthcare
linkedin.com/in/genetics-research-160337363/

Comments

Post a Comment

Popular posts from this blog

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...
Post a Comment
Read more

Post-Stroke Cardiovascular risks

Study finds genetic factors key to post-stroke cardiovascular risks In a recent study published in the journal Stroke , researchers identify genetic and molecular risk factors for subsequent cardiovascular outcomes after incident stroke in an effort to identify potential therapeutic targets to improve patient prognoses. Identifying the causes of stroke Stroke is a major global health issue that causes significant disability and mortality, particularly arterial ischemic stroke (AIS). AIS, which is a type of stroke caused by blocked blood flow to the brain, is responsible for up to 85% of stroke cases. AIS arises due to cerebral blood vessel blockage, with modifiable risk factors including hypertension, diabetes, dyslipidemia, atrial fibrillation, obesity, and lifestyle behaviors. Although genome-wide association studies (GWAS) often focus on incident strokes, studying subsequent events can provide new insights into stroke progression. Further research is crucial to identify genetic and...
Post a Comment
Read more

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...
Post a Comment
Read more